05.22.25 -- Investors Create A U.S. Biotech With GLP-1 Assets From China

We know how tough it can be to find the right CDMO, especially when capacity is tight and timelines are critical. That's why you’ll find our collection of recent Outsourced Pharma Capacity Update presentations so valuable. Our April Partners Week Update details the latest capabilities and available capacity from 40 leading CDMOs – and you can experience it all from the convenience of your screen. View the on-demand sessions for the modalities that fit your needs.

Gain valuable insights into advanced methods and analysis techniques for high-order structure, physiochemical characterization, cell-based and biochemical assays, and more.

Discover how building a product development program with a long-term vision and adopting a holistic PPQ and CPV strategy from the outset are now crucial.

Utilize these strategies to develop a functional equivalence model for single-use manufacturing equipment and assemblies for use in drug product manufacturing.

Data-driven, hybrid modeling complements mechanistic thinking by reducing computational load for faster decision-making when time is a critical consideration.

Here, we review examples of visible particle identification, the root cause investigation, and the performance of additional troubleshooting using advanced and innovative technologies.

Hear from experienced professionals in the drug delivery space on how to ensure success and speed-to-market by establishing a firm foundation when working with a CMO.

Proper formulation development has a huge impact on whether a technology transfer to clinical phase fill/finish is successful. Be aware of the challenges of transitioning a promising drug candidate.

In this study, we discuss the process of how a new fill line was planned for and implemented, while also considering how best to mitigate contamination risks.

To enable the development of optimized PLGA-based sustained release formulations, this paper offers essential insights into the polymer’s properties, fabrication techniques, and drug release mechanisms.

Learn how AI is transforming the biomanufacturing industry and how partnerships between pharmaceutical companies and academic institutions are poised to set the new standard.

Begin your ADC manufacturing journey by finding a partner who can provide support through every phase of the conjugate life cycle, including process optimization, scale-up, and validation.

Quality data for informed decision-making is well supported by a built-in network of lab digitization solutions and a commitment to the principles of data integrity.

Step into the future of facility management with Digital Twin Technology and create a virtual replica of your facility or equipment to enable the highest levels of operational readiness and excellence.

With the robot-assisted labeling cell 211R HC, HERMA shows how challenges in wrap-around labeling can be solved more effectively. Discover the advantages of our HERMA 211R HC labeling solution.

Experience a friendlier, more reliable approach to biopharmaceutical manufacturing with AGC Biologics, your trusted partner for minimizing risks and fostering collaboration.

Witness how our expertise and advanced capabilities provide customized analytical solutions that ensure quality, precision, and regulatory compliance for your biotherapeutics.

With a winning strategy encompassing safe, secure, and reliable supply chains to help you bring your therapy to patients, see how we can support your next project.

Biopharmaceutical development hinges on a robust CMC strategy. Our expertise allows us to collaboratively design the optimal suite of analytical studies tailored to your specific molecule.